Chronic obstructive pulmonary disease in older persons: A comparison of two spirometric definitions

被引:47
作者
Fragoso, Carlos A. Vaz [1 ,2 ]
Concato, John [1 ,2 ]
McAvay, Gail [2 ]
Van Ness, Peter H. [2 ]
Rochester, Carolyn L. [1 ,2 ]
Yaggi, H. Klar [1 ,2 ]
Gill, Thomas M. [2 ]
机构
[1] Vet Affairs VA Clin Epidemiol Res Ctr, West Haven, CT USA
[2] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA
关键词
Spirometry; Respiratory symptoms; Mortality; MORTALITY; RISK; REVERSIBILITY; EVENTS; COPD;
D O I
10.1016/j.rmed.2009.10.030
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background: Among older persons, we previously endorsed a two-step spirometric definition of chronic obstructive pulmonary disease (COPD) that requires a ratio of forced expiratory volume in 1 sec to forced vital capacity (FEV1/FVC) below 70, and an FEV1 below the 5th or 10th standardized residual percentile ("SR-tile strategy"). Objective: To evaluate the clinical validity of an SR-tile strategy, compared to a current definition of COPD, as published by the Global Initiative for Obstructive Lung Disease (GOLD-COPD), in older persons. Methods: We assessed national data from 2480 persons aged 65-80 years. In separate analyses, we evaluated the association of an SR-tile strategy with mortality and respiratory symptoms, relative to GOLD-COPD. As per convention, GOLD-COPD was defined solely by an FEV1/FVC < .70, with severity staged according to FEV1 cut-points at 80 and 50 percent predicted (%Pred). Results: Among 831 participants with GOLD-COPD, the risk of death was elevated only in 179 (21.5%) of those who also had an FEV1 < 5th SR-tile; and the odds of having respiratory symptoms were elevated only in 310 (37.4%) of those who also had an FEV1 < 10th SR-tile. In contrast, GOLD-COPD staged at an FEV1 50-79%Pred led to misclassification (overestimation) in terms of 209 (66.4%) and 77 (24.6%) participants, respectively, not having an increased risk of death or likelihood of respiratory symptoms. Conclusion: Relative to an SR-tile strategy, the majority of older persons with GOLD-COPD had neither an increased risk of death nor an increased likelihood of respiratory symptoms. These results raise concerns about the clinical validity of GOLD guidelines in older persons. Published by Elsevier Ltd.
引用
收藏
页码:1189 / 1196
页数:8
相关论文
共 34 条
[1]
LUNG-FUNCTION TESTING - SELECTION OF REFERENCE VALUES AND INTERPRETATIVE STRATEGIES [J].
不详 .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (05) :1202-1218
[2]
[Anonymous], AM J RESP CRIT CARE
[3]
[Anonymous], SPIROMETRY
[4]
[Anonymous], 2004, SUDAAN LANG MAN REL
[5]
The effects of a smoking cessation intervention on 14.5-year mortality - A randomized clinical trial [J].
Anthonisen, NR ;
Skeans, MA ;
Wise, RA ;
Manfreda, J ;
Kanner, RE ;
Connett, JE .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (04) :233-239
[6]
THE HORSE-RACING EFFECT AND PREDICTING DECLINE IN FORCED EXPIRATORY VOLUME IN ONE 2ND FROM SCREENING SPIROMETRY [J].
BURROWS, B ;
KNUDSON, RJ ;
CAMILLI, AE ;
LYLE, SK ;
LEBOWITZ, MD .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987, 135 (04) :788-793
[7]
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease [J].
Celli, BR ;
Cote, CG ;
Marin, JM ;
Casanova, C ;
de Oca, MM ;
Mendez, RA ;
Pinto Plata, V ;
Cabral, HJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (10) :1005-1012
[8]
CHERRY DK, 2001, ADV DATA VITAL HLTH, V322, P1
[9]
Clinical use of bone densitometry - Scientific review [J].
Cummings, SR ;
Bates, D ;
Black, DM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (15) :1889-1897
[10]
Inhaled Corticosteroids in Patients With Stable Chronic Obstructive Pulmonary Disease A Systematic Review and Meta-analysis [J].
Drummond, M. Bradley ;
Dasenbrook, Elliott C. ;
Pitz, Marshall W. ;
Murphy, David J. ;
Fan, Eddy .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (20) :2407-2416